Biogen’s Aduhelm Sales Total $2 Million in Second Quarternews2021-07-22T21:10:02+00:00July 22nd, 2021|The New York Times|
A New Alzheimer’s Drug Offers More Questions Than Answersnews2021-07-09T19:14:45+00:00July 9th, 2021|The New York Times|
In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drugnews2021-07-09T19:12:53+00:00July 9th, 2021|The New York Times|
